CN1081030C
(zh)
*
|
1996-02-07 |
2002-03-20 |
立德化学株式会社 |
含有曲尼司特的外用制剂及其制备方法
|
US6630168B1
(en)
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
US20050276836A1
(en)
*
|
1997-06-11 |
2005-12-15 |
Michelle Wilson |
Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
|
IT1292129B1
(it)
*
|
1997-06-11 |
1999-01-25 |
Sunnimex Ltd |
Medicamento utile per ridurre la massa grassa ed aumentare la massa magra nella donna in menopausa ed in entrambi i sessi nella
|
AU8779898A
(en)
*
|
1997-08-11 |
1999-03-01 |
Weider Nutrition International, Inc. |
Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
|
IL134263A
(en)
*
|
1997-08-21 |
2006-04-10 |
Gerolymatos P N Sa |
Pharmacological preparations containing pancoquinone for the treatment of Alzheimer's disease
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
AU4894697A
(en)
*
|
1997-10-01 |
1999-04-23 |
Flemington Pharmaceutical Corporation |
Buccal, polar and non-polar spray or capsule
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20040028735A1
(en)
*
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
US6146656A
(en)
*
|
1998-01-22 |
2000-11-14 |
Nitto Denko Corporation |
Percutaneous absorption preparation
|
US6011022A
(en)
*
|
1998-03-03 |
2000-01-04 |
El Khoury; George F. |
Topical application of muscarinic analgesic drugs such as neostigmine
|
US6239120B1
(en)
*
|
1998-03-17 |
2001-05-29 |
Pharmalink Ab |
Method and means for treating glomerulonephritis
|
PE20000354A1
(es)
|
1998-04-03 |
2000-05-20 |
Advanced Medicine Inc |
Nuevos compuestos y usos anestesicos locales
|
US6462034B1
(en)
|
1998-04-03 |
2002-10-08 |
Theravance, Inc. |
Local anesthetic compounds and uses
|
US6187790B1
(en)
|
1999-03-04 |
2001-02-13 |
Neal R. Cutler |
Use of cilostazol for treatment of sexual dysfunction
|
DE19827417B4
(de)
*
|
1998-06-19 |
2004-10-28 |
Hahn, Rainer, Dr.Med.Dent. |
Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
|
SE512224C2
(sv)
*
|
1998-06-26 |
2000-02-14 |
Medeikonos Ab |
Anordning för applicering av deltaaminolevulinsyra (ALA) på huden vid cancerdetektering och för skyddande av det med ALA-applicerade hudområdet mot lus
|
US6294188B1
(en)
|
1998-07-09 |
2001-09-25 |
Aviana Biopharm Inc. |
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
|
US6169094B1
(en)
*
|
1998-07-14 |
2001-01-02 |
Sanofi-Synthelabo |
Compositions of (S) (-)-amisulpride
|
DE69918124T2
(de)
*
|
1998-07-24 |
2004-10-21 |
Alza Corp |
Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam
|
US6699497B1
(en)
*
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
ES2211151T3
(es)
*
|
1998-08-19 |
2004-07-01 |
Skyepharma Canada Inc. |
Dispersiones acuosas inyectables de propofol.
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
SE9803240D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6337086B1
(en)
|
1999-02-06 |
2002-01-08 |
Dow Corning Corporation |
Pressure sensitive adhesive compositions for transdermal drug delivery devices
|
FR2790389B1
(fr)
*
|
1999-02-24 |
2002-10-18 |
Touche Marie Jose Sanglier |
Synergie entre un anesthesique local: le butamben-scuroforme et un antiseptique local: l'eugenol applications therapeutiques ou autres dans le domaine pharmaceutique, chirurgical, dentaire ou autre
|
US6399093B1
(en)
*
|
1999-05-19 |
2002-06-04 |
Advanced Medical Instruments |
Method and composition to treat musculoskeletal disorders
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6734192B1
(en)
*
|
1999-08-23 |
2004-05-11 |
Mp-1 Inc. |
Treatment of viral infections
|
US6451837B1
(en)
|
1999-09-01 |
2002-09-17 |
Andrius Baskys |
Neuroprotective effects of mitogen-activated protein kinase (MAPK) cascade inhibitors
|
EP1207852A4
(en)
|
1999-09-02 |
2009-11-11 |
Nostrum Pharmaceuticals Inc |
ORAL PHARMACEUTICALS WITH TAXED RELEASE FOR ORAL ADMINISTRATION
|
FR2798590B1
(fr)
*
|
1999-09-21 |
2001-11-30 |
Oreal |
Utilisation de l'alverine pour diminuer les rides
|
FR2799369B1
(fr)
*
|
1999-10-08 |
2001-12-21 |
Oreal |
Association d'escine et de sulfate de dextran et son utilisation
|
US7503493B2
(en)
*
|
1999-10-25 |
2009-03-17 |
Silverbrook Research Pty Ltd |
Method and system for digitizing freehand graphics with user-selected properties
|
US20050042271A1
(en)
*
|
1999-11-19 |
2005-02-24 |
Xel Herbaceuticals, Inc . |
Transdermal delivery system for alkaloids of aconitum species
|
AU1780101A
(en)
*
|
1999-11-19 |
2001-05-30 |
Xel Herbaceuticals |
Transdermal delivery system for alkaloids of aconitum species
|
US6896898B1
(en)
|
1999-11-19 |
2005-05-24 |
Xel Herbaceuticals, Inc. |
Transdermal delivery system for alkaloids of aconitum species
|
DE19957918A1
(de)
*
|
1999-11-25 |
2001-06-13 |
Ulrich Doht |
Desinfektionsreiniger zur Reinigung und Pflege sowie Verfahren zu seiner Herstellung
|
US6967023B1
(en)
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
US6730691B1
(en)
|
2000-02-10 |
2004-05-04 |
Miles A. Galin |
Uses of alpha adrenergic blocking agents
|
WO2002081628A2
(en)
*
|
2001-04-05 |
2002-10-17 |
Ribozyme Pharmaceuticals, Incorporated |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
US6579544B1
(en)
|
2000-05-31 |
2003-06-17 |
Nutriex, L.L.C. |
Method for supplementing the diet
|
JP4648518B2
(ja)
*
|
2000-06-01 |
2011-03-09 |
帝國製薬株式会社 |
4−ビフェニル酢酸含有貼付剤
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US20040214829A1
(en)
*
|
2000-07-14 |
2004-10-28 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
BR0112461A
(pt)
*
|
2000-07-14 |
2003-07-22 |
Allergan Inc |
Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
|
US8858961B2
(en)
|
2000-07-14 |
2014-10-14 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
WO2002005853A2
(en)
|
2000-07-14 |
2002-01-24 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
US20050026924A1
(en)
*
|
2000-07-14 |
2005-02-03 |
Allergan, Inc. |
Compositions containing alpha-2-adrenergic agonist components
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
AU2001282064B2
(en)
*
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
GB0021317D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Queen Mary & Westfield College |
Transdermal pharmaceutical delivery composition
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
MXPA03003401A
(es)
*
|
2000-10-16 |
2004-06-30 |
Neopharm Inc |
Formulacion liposomica de mitoxantrona.
|
US20020198215A1
(en)
*
|
2000-10-23 |
2002-12-26 |
Lino Tavares |
Terazosin transdermal device and methods
|
US7025992B2
(en)
*
|
2001-02-14 |
2006-04-11 |
Gw Pharma Limited |
Pharmaceutical formulations
|
US6730330B2
(en)
*
|
2001-02-14 |
2004-05-04 |
Gw Pharma Limited |
Pharmaceutical formulations
|
ATE525061T1
(de)
*
|
2001-02-28 |
2011-10-15 |
Axiomedic Ltd |
Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
|
US8980334B2
(en)
*
|
2001-02-28 |
2015-03-17 |
Axiomedic Ltd. |
Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
EP1390084B1
(en)
*
|
2001-05-01 |
2011-03-23 |
A.V. Topchiev Institute of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US8728445B2
(en)
|
2001-05-01 |
2014-05-20 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences |
Hydrogel Compositions
|
CA2446060A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
US20020187181A1
(en)
*
|
2001-05-14 |
2002-12-12 |
3M Innovative Properties Company |
System for delivering cosmetics and pharmaceuticals
|
US20030212078A1
(en)
*
|
2001-05-17 |
2003-11-13 |
Klein Gerald L. |
Topical administration of pharmacological compositions for non-systemic treatment of pruritus
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
EP1435945B1
(en)
*
|
2001-06-05 |
2008-08-13 |
Aung-din, Ronald |
Topical migraine therapy
|
US20030036556A1
(en)
*
|
2001-06-29 |
2003-02-20 |
Jennings Julianne E. |
Zonisamide use in headache
|
AU2002365681A1
(en)
*
|
2001-12-04 |
2003-06-17 |
Kag Holding A/S |
Screw pump for transporting emulsions susceptible to mechanical handling
|
AU2002360665A1
(en)
*
|
2001-12-20 |
2003-07-09 |
Cogent Neuroscience, Inc. |
Methods for treating conditions, disorders, or diseases involving cell death
|
EP1455849B1
(en)
*
|
2001-12-21 |
2005-11-23 |
Coloplast A/S |
A wound care device
|
AU2003210517A1
(en)
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
US20030175360A1
(en)
*
|
2002-02-22 |
2003-09-18 |
Renzo Luzzatti |
Symptomatic relief of gastrointestinal disorders
|
US20040029941A1
(en)
*
|
2002-05-06 |
2004-02-12 |
Jennings Julianne E. |
Zonisamide use in obesity and eating disorders
|
US20050215552A1
(en)
*
|
2002-05-17 |
2005-09-29 |
Gadde Kishore M |
Method for treating obesity
|
EP2301537A1
(en)
*
|
2002-05-17 |
2011-03-30 |
Duke University |
Zonisamide for the treatment of obesity
|
US7217853B2
(en)
|
2002-05-24 |
2007-05-15 |
Corium International, Inc. |
Composition for cushions, wound dressings and other skin-contacting products
|
US6900203B2
(en)
|
2002-06-19 |
2005-05-31 |
Polium Technologies, Inc. |
Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them
|
WO2004006902A1
(en)
*
|
2002-07-10 |
2004-01-22 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
|
US20040010035A1
(en)
*
|
2002-07-15 |
2004-01-15 |
Ciociola Arthur A. |
Gastrointestinal compositions
|
US6986901B2
(en)
*
|
2002-07-15 |
2006-01-17 |
Warner-Lambert Company Llc |
Gastrointestinal compositions
|
EP1551457A1
(en)
*
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Liquid dosage compositions of stable nanoparticulate active agents
|
US20040037895A1
(en)
*
|
2002-08-23 |
2004-02-26 |
Alex Zhu |
Methods of treating involuntary facial spasms and facial wrinkles
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US20070292355A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Anti-infection augmentation foamable compositions and kit and uses thereof
|
US20060018937A1
(en)
*
|
2002-10-25 |
2006-01-26 |
Foamix Ltd. |
Steroid kit and foamable composition and uses thereof
|
MXPA05004278A
(es)
*
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
US20050271596A1
(en)
*
|
2002-10-25 |
2005-12-08 |
Foamix Ltd. |
Vasoactive kit and composition and uses thereof
|
US20050186142A1
(en)
*
|
2002-10-25 |
2005-08-25 |
Foamix Ltd. |
Kit and composition of imidazole with enhanced bioavailability
|
US20070292359A1
(en)
*
|
2002-10-25 |
2007-12-20 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US7704518B2
(en)
*
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US8119109B2
(en)
*
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US20060193789A1
(en)
*
|
2002-10-25 |
2006-08-31 |
Foamix Ltd. |
Film forming foamable composition
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US7700076B2
(en)
*
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US20080206161A1
(en)
*
|
2002-10-25 |
2008-08-28 |
Dov Tamarkin |
Quiescent foamable compositions, steroids, kits and uses thereof
|
US8486376B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US20050205086A1
(en)
*
|
2002-10-25 |
2005-09-22 |
Foamix Ltd. |
Retinoid immunomodulating kit and composition and uses thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US20080317679A1
(en)
*
|
2002-10-25 |
2008-12-25 |
Foamix Ltd. |
Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
|
US10117812B2
(en)
*
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US6984128B2
(en)
*
|
2002-11-01 |
2006-01-10 |
Bas Medical, Inc. |
Methods for enabling and stabilizing tooth movement
|
ATE552824T1
(de)
*
|
2002-11-05 |
2012-04-15 |
Fadim S R L |
Kontrollierte und kontinuierliche verabreichung von rifaximin
|
DE10252726B4
(de)
*
|
2002-11-13 |
2008-05-08 |
Lts Lohmann Therapie-Systeme Ag |
Mehrschichtiges transmucosales therapeutisches System
|
US20040091551A1
(en)
*
|
2002-11-13 |
2004-05-13 |
Al-Karim Damji |
Topical composition and application system
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
SI2316456T1
(sl)
*
|
2003-04-29 |
2017-10-30 |
Orexigen Therapeutics, Inc. |
Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
|
EP1633408B1
(en)
|
2003-06-19 |
2016-08-17 |
Coloplast A/S |
A wound care device
|
CA2529528A1
(en)
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
|
ES2237298B1
(es)
*
|
2003-07-16 |
2006-11-01 |
Italfarmaco, S.A. |
Formulaciones mucoadhesivas semisolidas.
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
*
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US20050187278A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
US20060160750A1
(en)
*
|
2004-01-13 |
2006-07-20 |
Krishnan K R R |
Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss
|
US7713959B2
(en)
*
|
2004-01-13 |
2010-05-11 |
Duke University |
Compositions of an anticonvulsant and mirtazapine to prevent weight gain
|
WO2005070461A2
(en)
|
2004-01-13 |
2005-08-04 |
Duke University |
Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
KR20140104986A
(ko)
*
|
2004-02-17 |
2014-08-29 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
US20050226920A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Kirk Voelker |
Method of decreasing nicotine withdrawal symptoms during smoking cessation.
|
US20060100205A1
(en)
*
|
2004-04-21 |
2006-05-11 |
Eckard Weber |
Compositions for affecting weight loss
|
CA2505836C
(en)
*
|
2004-05-06 |
2013-08-27 |
Alcon Inc. |
Topical brimonidine tartrate formulations that lack chlorine dioxide
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US7666914B2
(en)
*
|
2004-06-03 |
2010-02-23 |
Richlin David M |
Topical preparation and method for transdermal delivery and localization of therapeutic agents
|
CN101039706A
(zh)
*
|
2004-08-05 |
2007-09-19 |
考里安国际公司 |
粘合剂组合物
|
US9028852B2
(en)
|
2004-09-07 |
2015-05-12 |
3M Innovative Properties Company |
Cationic antiseptic compositions and methods of use
|
US20060115782A1
(en)
*
|
2004-11-30 |
2006-06-01 |
Chunhua Li |
Systems and methods for coating a dental appliance
|
US7947508B2
(en)
*
|
2004-11-30 |
2011-05-24 |
Align Technology, Inc. |
Systems and methods for intra-oral diagnosis
|
US20060115785A1
(en)
|
2004-11-30 |
2006-06-01 |
Chunhua Li |
Systems and methods for intra-oral drug delivery
|
US7766658B2
(en)
*
|
2004-11-30 |
2010-08-03 |
Align Technology, Inc. |
Systems and methods for intra-oral diagnosis
|
AR048742A1
(es)
*
|
2004-12-22 |
2006-05-24 |
Gador Sa |
Sistema de aplicacion de medicamentos intra-oral
|
US8501818B2
(en)
*
|
2005-03-14 |
2013-08-06 |
Ceptaris Therapeutics, Inc. |
Stabilized compositions of alkylating agents and methods of using same
|
US20110039943A1
(en)
*
|
2005-03-14 |
2011-02-17 |
Robert Alonso |
Methods for treating skin disorders with topical nitrogen mustard compositions
|
US7872050B2
(en)
*
|
2005-03-14 |
2011-01-18 |
Yaupon Therapeutics Inc. |
Stabilized compositions of volatile alkylating agents and methods of using thereof
|
US20090117054A1
(en)
*
|
2005-03-29 |
2009-05-07 |
University Of Kentucky Research Foundation |
Sublingual spray for the treatment of pain
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
US20060241002A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Rogozinski Wallace J |
Sodium hypochlorite gel composition
|
CA2610662A1
(en)
*
|
2005-05-09 |
2007-05-18 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US20060275237A1
(en)
*
|
2005-05-09 |
2006-12-07 |
Bissett Donald L |
Skin care compositions containing idebenone
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
KR20080031208A
(ko)
*
|
2005-05-25 |
2008-04-08 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
야반 불면증을 치료하기 위한 고체 조성물 및 방법
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
US20080152596A1
(en)
*
|
2005-07-19 |
2008-06-26 |
Foamix Ltd. |
Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
|
US20090214643A1
(en)
*
|
2005-07-19 |
2009-08-27 |
Franklin Amie E |
Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
|
US20070082070A1
(en)
*
|
2005-10-11 |
2007-04-12 |
Stookey Evangeline L |
Treating skin disorders
|
SI1937276T1
(sl)
|
2005-10-12 |
2013-04-30 |
Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road |
Izboljšani testosteronski gel in postopek uporabe
|
US8013011B2
(en)
*
|
2005-10-20 |
2011-09-06 |
Epipharm Gmbh |
Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof
|
EP2135603B1
(en)
*
|
2005-11-22 |
2013-01-02 |
Orexigen Therapeutics, Inc. |
Compositions and methods for increasing insulin sensitivity
|
KR101402592B1
(ko)
*
|
2006-03-06 |
2014-06-17 |
에스케이바이오팜 주식회사 |
피록시캄-무기물 복합체를 포함하는 경피투여 조성물 및이를 이용한 패치시스템
|
US20070248548A1
(en)
*
|
2006-04-19 |
2007-10-25 |
Blondino Frank E |
Stable hydroalcoholic oral spray formulations and methods
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
MX2009002536A
(es)
*
|
2006-09-08 |
2009-04-14 |
Foamix Ltd |
Composicion espumable coloreada o coloreable y espuma.
|
PT2117521E
(pt)
|
2006-11-03 |
2012-09-10 |
Durect Corp |
Sistemas de administração transdérmica que compreendem bupivacaína
|
KR20150082689A
(ko)
*
|
2006-11-09 |
2015-07-15 |
오렉시젠 세러퓨틱스 인크. |
단위 용량 팩키지
|
KR101735466B1
(ko)
|
2006-11-09 |
2017-05-15 |
오렉시젠 세러퓨틱스 인크. |
신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
|
US20080206155A1
(en)
*
|
2006-11-14 |
2008-08-28 |
Foamix Ltd. |
Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
|
US20080260655A1
(en)
*
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
EP2124897A4
(en)
*
|
2006-12-22 |
2012-05-09 |
Novadel Pharma Inc |
SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS
|
EP1986473B1
(en)
*
|
2007-04-03 |
2017-01-25 |
Tsinghua University |
Organic electroluminescent device
|
AU2008251370A1
(en)
*
|
2007-05-10 |
2008-11-20 |
Novadel Pharma Inc. |
Anti-insomnia compositions and methods
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
WO2009026178A2
(en)
*
|
2007-08-17 |
2009-02-26 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
US7985325B2
(en)
*
|
2007-10-30 |
2011-07-26 |
Novellus Systems, Inc. |
Closed contact electroplating cup assembly
|
US20090130029A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Foamix Ltd. |
Glycerol ethers vehicle and pharmaceutical compositions thereof
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
HUP0700828A2
(en)
*
|
2007-12-20 |
2010-01-28 |
Richter Gedeon Nyrt |
Transdermal pharmaceutical compositions containing tolperisone alone and in combination
|
AU2009205314A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
WO2009107098A2
(en)
*
|
2008-02-27 |
2009-09-03 |
Nozizwe Ndlovu |
An oral treatment composition
|
LT3494960T
(lt)
*
|
2008-03-27 |
2021-02-25 |
Helsinn Healthcare Sa |
Stabilizuotos alkilinimo agentų kompozicijos ir jų naudojimo būdai
|
US20090246256A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Al-Ghananeem Abeer M |
Compositions and Methods for Transmucosal Delivery of Lofexidine
|
CA2725930A1
(en)
*
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
US8729108B2
(en)
*
|
2008-06-17 |
2014-05-20 |
Christopher J Dannaker |
Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
|
US8592424B2
(en)
|
2008-06-30 |
2013-11-26 |
Afgin Pharma Llc |
Topical regional neuro-affective therapy
|
ES2344673B1
(es)
*
|
2008-08-07 |
2011-05-03 |
Italfarmaco, S.A. |
Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
|
US8119694B2
(en)
|
2008-08-15 |
2012-02-21 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
JP5472756B2
(ja)
|
2008-10-02 |
2014-04-16 |
マイラン・インク |
多層接着ラミネートの作製方法
|
ES2344675B1
(es)
|
2008-12-19 |
2011-04-28 |
Italfarmaco, S.A. |
Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
|
AU2010204986B2
(en)
|
2009-01-14 |
2016-06-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
CA2760186C
(en)
|
2009-04-28 |
2019-10-29 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011039638A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Topical tetracycline compositions
|
US8551781B2
(en)
|
2009-11-19 |
2013-10-08 |
The Regents Of The University Of California |
Vault complexes for facilitating biomolecule delivery
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
US9320742B2
(en)
*
|
2009-12-01 |
2016-04-26 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
CN102724878A
(zh)
*
|
2010-01-11 |
2012-10-10 |
奥雷西根治疗公司 |
在重度抑郁症患者中提供体重减轻疗法的方法
|
US10478505B2
(en)
|
2011-09-23 |
2019-11-19 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
ES2885523T3
(es)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd Inc |
Formulaciones y terapias de reposición hormonal de combinación naturales
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN112472814A
(zh)
|
2012-01-23 |
2021-03-12 |
萨奇治疗股份有限公司 |
神经活性类固醇制剂和治疗中枢神经系统障碍的方法
|
DK3730132T3
(da)
|
2012-06-06 |
2022-08-08 |
Nalpropion Pharmaceuticals Llc |
Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PT2887944T
(pt)
*
|
2012-08-21 |
2022-01-10 |
Sage Therapeutics Inc |
Alopregnanolona para tratamento do estado de mal epiléptico refratário
|
US9717697B2
(en)
|
2012-10-15 |
2017-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for the transdermal delivery of methylphenidate
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
US8936814B2
(en)
*
|
2012-11-30 |
2015-01-20 |
Zuri A. Murrell |
Skin cream
|
AU2013352141B2
(en)
|
2012-11-30 |
2018-04-05 |
The Regents Of The University Of California |
Anticonvulsant activity of steroids
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
WO2014106016A1
(en)
|
2012-12-28 |
2014-07-03 |
Noven Pharmaceuticals, Inc |
Multi-polymer compositions for transdermal drug delivery
|
US9314470B2
(en)
|
2012-12-28 |
2016-04-19 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
BR112015032929B1
(pt)
|
2013-07-03 |
2022-08-23 |
Lts Lohmann Therapie-Systeme Ag |
Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico
|
WO2015138919A1
(en)
|
2014-03-14 |
2015-09-17 |
The University Of North Carolina At Chapel Hill |
Small molecules for inhibiting male fertility
|
CN106456567A
(zh)
|
2014-05-20 |
2017-02-22 |
Lts勒曼治疗系统股份公司 |
在经皮递送系统中调节活性剂释放的方法
|
CN106456566B
(zh)
|
2014-05-20 |
2020-06-16 |
Lts勒曼治疗系统股份公司 |
含罗替戈汀的经皮递送系统
|
US11752110B2
(en)
|
2014-05-20 |
2023-09-12 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system including an interface mediator
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
JP6807848B2
(ja)
|
2015-02-06 |
2021-01-06 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
経皮薬物送達のための感圧粘着剤
|
US10406116B2
(en)
|
2015-02-06 |
2019-09-10 |
Noven Pharmaceuticals, Inc. |
Pressure-sensitive adhesives for transdermal drug delivery
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
TWI798173B
(zh)
|
2016-03-08 |
2023-04-11 |
美商賽吉醫療公司 |
神經活性類固醇,其組合物及用途
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
CA3045078C
(en)
*
|
2016-11-28 |
2022-04-12 |
Pola Chemical Industries, Inc. |
Wrinkle ameliorating agent
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|